Some progress has been made in recent years in lowering the cost of generic drugs used in the health system and bought by patients. But it has been painfully slow.
This newspaper has, on a number of occasions, highlighted the huge price gaps between what the HSE pays for medicines and what is paid internationally by other state agencies, such as the NHS in Britain.
Legislation introduced last year was meant to address this, and...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team